Innovative patient-specific delivered-dose prediction for volumetric modulated arc therapy using lightweight Swin-Transformer

利用轻型Swin-Transformer实现针对容积调强弧形治疗的创新型患者个体化剂量预测

阅读:1

Abstract

BACKGROUND: Volumetric modulated arc therapy (VMAT) necessitates rigorous pre-treatment patient-specific quality assurance (PSQA) to ensure dosimetric accuracy, yet conventional manual verification methods encounter time and labor constraints in clinical workflows. While deep learning (DL) models have advanced PSQA by automating metrics prediction, existing approaches relying on convolutional neural networks struggle to reconcile local feature extraction with global contextual awareness. This study aims to develop a novel lightweight DL framework that synergizes hierarchical spatial feature learning and computational efficiency to enhance VMAT-delivered dose (VTDose) prediction. METHODS: We propose a hybrid architecture featuring a novel hierarchical fusion framework that synergizes shifted-window self-attention with adaptive local-global feature interaction. (termed "STQA"). Specially, strategic replacement of Swin-Transformer blocks with ResNet residual modules in deep layers, coupled with depthwise separable attention mechanisms, enables 40% parameter reduction while preserving spatial resolution. The model was trained on multimodal inputs and evaluated against state-of-the-art methods using structural similarity index (SSIM), mean absolute error (MAE), root mean square error (RMSE), and gamma passing rate (GPR). RESULTS: Visual evaluation of VTDose and discrepancy maps across axial, coronal, and sagittal planes demonstrated enhanced fidelity of STQA to ground truth (GT). Quantitative analysis revealed superior performance of STQA across all evaluation metrics: SSIM=0.978, MAE=0.163, and RMSE= 0.416. GPR analysis confirmed clinical applicability, with STQA achieving 95.43%±3.41% agreement with GT (94.63%±2.84%). CONCLUSIONS: STQA establishes a paradigm for efficient and accurate VTDose prediction. Its lightweight design, validated through multi-site clinical data, addresses critical limitations in current DL-based PSQA, offering a clinically viable solution to enhance radiotherapy PSQA workflows.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。